mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
4e-07 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
4e-07 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
1e-06 |
mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
2e-06 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
2e-06 |
mRNA |
AEW541 |
CCLE |
pan-cancer |
AAC |
0.22 |
2e-06 |
mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
5e-06 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
5e-06 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
6e-06 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
6e-06 |